Fidelity Investments
BIOR

Fidelity Investments’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Fidelity Investments’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8
Closed -$108 – 5847
2023
Q4 		$108 Buy
+8
New +$130 ﹤0.01% 4936
2023
Q3 		– Sell
-3
Closed -$100 – 5667
2023
Q2 		$100 Buy
+3
New +$106 ﹤0.01% 4958
2023
Q1 		– Hold
0
– -$1 – 5673
2022
Q4 		– Hold
0
– – – 5331

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Fidelity Investments's BIOR Position: Q1 2024 in Review

Fidelity Investments sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2024, closing a stake of 8 shares — an estimated $108 sold.

Fidelity Investments first reported a position in BIOR in Q2 2023 and held it in 2 quarters. The position peaked at $108 in Q4 2023. 27 funds tracked by Wall St. Rank hold BIOR as of Q1 2024.

  • Fidelity Investments reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Fidelity Investments sold 8 Biora Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $108.
  • Fidelity Investments first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Fidelity Investments's Biora Therapeutics, Inc. Common Stock position peaked at $108 in Q4 2023.
  • 27 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Fidelity Investments's 13F filing for Q1 2024, filed 13 May 2024.